
Inogen INGN
$ 6.54
1.87%
Annual report 2025
added 02-27-2026
Inogen DIO Ratio 2011-2026 | INGN
Annual DIO Ratio Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.7 | 47 | 54 | 53.8 | 57 | 64.8 | 68.5 | 55 | 53.6 | 49.6 | 38.1 | 48.8 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 68.5 | 38.1 | 53.2 |
Quarterly DIO Ratio Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.1 | 45.3 | 50.8 | - | 45.5 | 48.2 | 48.5 | - | 49.8 | 64 | 80.3 | - | 26 | 27.2 | 66.3 | - | 59.3 | 47.8 | 49.6 | - | 54.8 | 58.1 | 55 | - | 67.2 | 64 | 62.5 | - | 53.1 | 50.6 | 50.7 | - | 48 | 52.8 | 56.6 | - | 44.7 | 46.2 | 48.3 | - | 36.9 | 34 | 41.9 | - | 47.1 | 45.5 | 46.3 | - | 38.2 | 42.6 | 25.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 80.3 | 25.4 | 49.3 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M | ||
|
Helius Medical Technologies
HSDT
|
327 | $ 2.01 | -6.94 % | $ 1.22 M | ||
|
Aziyo Biologics
AZYO
|
146 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
205 | $ 9.5 | -0.52 % | $ 732 M | ||
|
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | ||
|
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
160 | - | - | $ 16.4 M | ||
|
Delcath Systems
DCTH
|
266 | $ 9.12 | -0.87 % | $ 327 M | ||
|
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | ||
|
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | ||
|
Outset Medical
OM
|
269 | $ 3.49 | -1.13 % | $ 53.1 K | ||
|
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | ||
|
Sintx Technologies
SINT
|
435 | $ 2.41 | -5.82 % | $ 6.68 M | ||
|
CONMED Corporation
CNMD
|
205 | $ 36.24 | -2.27 % | $ 1.12 B | ||
|
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
91.2 | $ 24.5 | -0.65 % | $ 207 M | ||
|
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
10.1 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
106 | $ 0.61 | -9.13 % | $ 33.2 M | ||
|
Sensus Healthcare
SRTS
|
288 | $ 4.04 | -4.38 % | $ 66 M | ||
|
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | ||
|
Smith & Nephew plc
SNN
|
357 | $ 32.28 | -0.52 % | $ 23.8 B | ||
|
LivaNova PLC
LIVN
|
127 | $ 64.3 | 1.58 % | $ 3.51 B | ||
|
InspireMD
NSPR
|
172 | $ 1.73 | -1.14 % | $ 111 M | ||
|
AdaptHealth Corp.
AHCO
|
20.2 | $ 11.32 | -0.61 % | $ 1.53 B | ||
|
Penumbra
PEN
|
332 | $ 337.62 | 0.4 % | $ 13.1 B | ||
|
Stryker Corporation
SYK
|
203 | $ 333.54 | 1.83 % | $ 127 B | ||
|
MiMedx Group
MDXG
|
123 | $ 3.98 | -3.05 % | $ 588 M | ||
|
TELA Bio
TELA
|
170 | $ 0.73 | 5.78 % | $ 34.3 M | ||
|
Invacare Corporation
IVC
|
82.8 | - | - | $ 24.7 M | ||
|
Myomo
MYO
|
81.8 | $ 0.68 | -2.34 % | $ 28.5 M | ||
|
NanoVibronix
NAOV
|
856 | - | - | $ 1.08 M | ||
|
Tandem Diabetes Care
TNDM
|
108 | $ 23.13 | -4.66 % | $ 1.57 B | ||
|
Inspire Medical Systems
INSP
|
309 | $ 50.84 | -1.11 % | $ 1.49 B | ||
|
Pulmonx Corporation
LUNG
|
256 | $ 1.29 | -0.77 % | $ 52.5 M | ||
|
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
355 | - | - | $ 2.07 B |